Overview

A Study in People With Abnormal Fat Levels in the Blood

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine: - The safety of the study medication and any side effects that might be associated with it; - Whether the study medication can help patients with low levels of 'good' cholesterol (HDL-C) and high blood fats or triglycerides (TG); - How much of the study medication should be given to patients; - How the study medication compares to fenofibrate (Lofibra), a drug used for people with low levels of HDL-C and high levels of TG.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company